• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Conference Coverage
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Digital Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Pharmacy
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Resources
CBD in Pets
CE Requirements by State
Contests
Veterinary Heroes
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Report proposes two options for Kansas National Bio and Agro-Defense Facility

July 18, 2012

National Research Council backs original plan but says downsized laboratory could be more efficient and cost-effective.

A subcommittee of the government-backed National Research Council released a report July 13 furthering progress toward the National Bio and Agro-Defense Facility (NBAF) to be built on the campus of Kansas State University in Manhattan, Kan. The committee provided the Department of Homeland Security two viable options for moving forward with the large-animal biocontainment laboratory, which the report deemed “imperative” to protect animal and public health.

The report concluded that the NBAF as it is currently designed--a Biosafety Level 4 facility--is the "ideal laboratory infrastructure in a single location." The committee believes the design meets the current and anticipated needs of the Department of Homeland Security and the U.S. Department of Agriculture’s Agricultural Research Service and Animal and Plant Health Inspection Service. But the proposed facility includes substantial costs in regard to construction, operation and management.

A second option would create a downsized laboratory that would operate in partnership with "a distributed laboratory network." The report said this option could potentially be more efficient and more cost-effective than the initial plan, although the savings are yet unknown.

The committee rejected a third option to maintain the Plum Island Animal Disease Center in New York while outsourcing Biosafety Level 4 needs to foreign laboratories. "Given the uncertainty over priorities of a foreign laboratory and logistical difficulties in an emergency, it would not be desirable for the United States to rely on international laboratories to meet these needs in the long term," the report states.

Kansas State University President Kirk Schulz and Ron Trewyn, Kansas State vice president for research, were pleased with the committee’s report.

Advertisement

"It is a vote of confidence for NBAF in its currently planned form, and shows confidence in Kansas and the capabilities of United States researchers to effectively address emerging animal diseases that threaten the nation," Schulz says. "We anticipate Kansas State playing an even more crucial role in that future security through our various animal and plant research initiatives. Moreover, we remain confident in our elected officials and agency planners as they work together to complete NBAF."

In its report the committee says the scope of its analysis was limited to examining the three options and explicitly excluded a risk assessment of specific site locations for the proposed laboratory facility. The report "neither compares relative risks of the three options nor determines where foot-and-mouth disease research can be safely conducted." The committee concludes that the concerns and risks associated with the creation of a Biosafety Level 4 facility "will need to be considered in a more comprehensive assessment."

The organization No NBAF in Kansas continues to oppose the facility. The group of "concerned citizens" states on its website that it believes the "facility would be too dangerous to have anywhere on the U.S. mainland, but especially in Manhattan (Kan.)."

Related Content:

MedicalLaw & EthicsBreaking News
Tips and tricks for diagnosing canine osteoarthritis early
Tips and tricks for diagnosing canine osteoarthritis early
Performing surgery on dogs with GDV
Performing surgery on dogs with GDV
Not-so-ordinary ER cases you should know
Not-so-ordinary ER cases you should know

Advertisement

Latest News

Thriving when life is hard

Hospital design expert shares his favorite design element

Updated EquiTrace app integrates wth HISA Portal

San Francisco SPCA receives $100k grant from San Francisco Foundation

View More Latest News
Advertisement